the remaining guarantee EBITDA and found that existing risk and reward were insignificant. The Company has therefore reversed deferred revenue amounting to THB 2,100.6 mm to statement of comprehensive
. Despite, the Company issued newly ordinary shares and warrants totally worth 3,894 million baht to its existing shareholders as well as to the specific investor (Private Placement) in Q1 2018, and the
General Meeting of Shareholders No. 1/2018 considers and approves the reduction of the Company’s registered capital by Baht 89,200,714 from the existing Baht 259,250,000 to Baht 170,049,286, by means of
capital by Baht 89,200,714 from the existing Baht 259,250,000 to Baht 170,049,286, by means of reduction of 89,200,714 unissued shares of the Company at a par value of Baht 1.00 per share, reserved for the
project completed and started transfer in November 2016 while the rest were continuing revenue from existing completed projects. In 2016 there were 4 projects completed and started transfer ,Manor
installations of new machines throughout the year 2017. So, the Company had an increase in production capacity beginning from Q2/2017 for existing products as well as new high-end products, which enabled the
reasons: Unit: Million Baht - The General Patient revenue for Q1/2019 were Baht 1,396.6 million which increased from Q1/2018 by Baht 192.3 million or 16.0% as a result of constantly growing of the existing
required for the production competent and the employee training program. Contract Period 1 Year (January 1st, 2018 – December 31st, 2018) Other conditions shall be in accordance with the existing agreement